The North America pulmonary pressure monitors market size is expected to reach US$ 2,725.9 million by 2033 from US$ 1,536.1 million in 2024. The market is estimated to record a CAGR of 8.0% from 2025 to 2033.
The pulmonary pressure monitors market in North America is experiencing significant growth driven by the growing incidence of pulmonary hypertension and COPD, advancements in non-invasive and portable monitoring technologies, and rising demand for remote respiratory monitoring in home care. Based on the clinical sophistication being one of its major features, high adoption rates, and strong integration across cardiopulmonary care pathways are prevalent in North America. The region takes advantage of a well-structured healthcare system, broad insurance coverage, and a lot of attention being given to early diagnosis and chronic disease management. Pulmonary pressure monitors are standard instruments in hospitals as well as clinics, and are mainly utilized in the diagnosis and treatment of pulmonary hypertension, heart failure, and COPD. This market is very competitive, with leading medical device manufacturers offering a wide range of invasive and non-invasive solutions that can be customized for hospital systems, specialty clinics, and home care. Technological differentiation, such as wireless connectivity, real-time analytics, and interoperability with electronic health records, is, for example, one of the main factors that influence procurement decisions. Regulatory clarity from agencies like the FDA enables product approvals to be fast, thus, it is a great promoter of innovation. While the US is the main country in terms of clinical volume and device penetration, the Canadian market is mostly influenced by centralized procurement and value-based care initiatives.
North America Pulmonary Pressure Monitors Market Strategic Insights
Key segments that contributed to the derivation of the pulmonary pressure monitors market analysis are product and end user.
The conjunction of clinical requirements, digital changes and policy encouragement for remote monitoring substantially influences the prospects for pulmonary pressure monitors in the US and Canada. As healthcare systems move towards value-based models, the importance of preventive care and continuous patient tracking is becoming more visible, which non-invasive and wearable monitoring technologies can benefit. The development of telehealth and home-based care, which has been accelerated by pandemic-era reforms, has led to the creation of new device deployment avenues, particularly for the elderly populations and the chronic disease cohorts. Artificial intelligence and machine learning are becoming more and more part of the monitoring platforms, thus they become predictive inferences and personalized treatment adjustments. Reimbursement schemes are changing to facilitate remote diagnostics, with CMS and private payers widening the coverage for digital monitoring tools. Growth will be influenced by the strategic collaborations between medical device companies, health care systems, and data platforms.
Based on region, the North America pulmonary pressure monitors market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.
Analysis of the three countries that make North America shows that the health care dynamics are different in each, and this has resulted in diverse consumer behaviours in terms of health care, regulatory environment, and the ecosystem for innovation. The US market is characterized by the quick acceptance of new technology, a wide range of provider networks, and stiff competition among device manufacturers. It is the academic medical centers and integrated delivery networks, which are at the forefront of testing new monitoring technologies and setting clinical standards, that therefore have a major impact. On the other hand, Canada functions under a publicly funded healthcare system, and there is central procurement and a strong emphasis on cost-effectiveness. The introduction of pulmonary pressure monitors is a result of provincial health authorities and clinical guidelines that stress the management of chronic disease. Mexico is a country that holds endless possibilities in its private hospitals and specialty clinics, where they are progressively moving towards advanced cardiopulmonary diagnostics. Differences in infrastructure and reimbursement are the main reasons for the slower spread of the technology. Across the region, urban areas are the ones where the device is most commonly used, while the villages and underprivileged areas are the ones that can be opened up by the scalable, portable, and affordable monitoring solutions.
North America Pulmonary Pressure Monitors Market Report Highlights| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 1,536.1 Million |
| Market Size by 2033 | US$ 2,725.9 Million |
| CAGR (2025 - 2033) | 8.0% |
| Historical Data | 2022-2023 |
| Forecast period | 2025-2033 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| North America | United States, Canada, Mexico |
| Market leaders and key company profiles |
|
Medtronic Plc, GE HealthCare Technologies Inc, Koninklijke Philips NV, Baxter International Inc, Becton Dickinson and Co, Abbott Laboratories, Terumo Corp, Dragerwerk AG & Co KGaA, ICU Medical, and Edwards Lifesciences, are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The North America Pulmonary Pressure Monitors Market is valued at US$ 1,536.1 Million in 2024, it is projected to reach US$ 2,725.9 Million by 2033.
As per our report North America Pulmonary Pressure Monitors Market, the market size is valued at US$ 1,536.1 Million in 2024, projecting it to reach US$ 2,725.9 Million by 2033. This translates to a CAGR of approximately 8.0% during the forecast period.
The North America Pulmonary Pressure Monitors Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pulmonary Pressure Monitors Market report:
The North America Pulmonary Pressure Monitors Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Pulmonary Pressure Monitors Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Pulmonary Pressure Monitors Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)